T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes

Jeffrey Babad, Ari Geliebter, Teresa P. DiLorenzo

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Summary: The non-obese diabetic (NOD) mouse model of autoimmune (type 1) diabetes has contributed greatly to our understanding of disease pathogenesis and has facilitated the development and testing of therapeutic strategies to combat the disease. Although the model is a valuable immunological tool in its own right, it reaches its fullest potential in areas where its findings translate to the human disease. Perhaps the foremost example of this is the field of T-cell antigen discovery, from which diverse benefits can be derived, including the development of antigen-specific disease interventions. The majority of NOD T-cell antigens are also targets of T-cell autoimmunity in patients with type 1 diabetes, and several of these are currently being evaluated in clinical trials. Here we review the journeys of these antigens from bench to bedside. We also discuss several recently identified NOD T-cell autoantigens whose translational potential warrants further investigation.

Original languageEnglish (US)
Pages (from-to)459-465
Number of pages7
JournalImmunology
Volume131
Issue number4
DOIs
StatePublished - Dec 2010

Fingerprint

Inbred NOD Mouse
Autoantigens
Type 1 Diabetes Mellitus
T-Lymphocytes
Viral Tumor Antigens
Antigens
Autoimmunity
Clinical Trials
Therapeutics

Keywords

  • Autoantigens
  • Autoimmune diabetes
  • Non-obese diabetic mice
  • Therapies
  • Type 1 diabetes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes. / Babad, Jeffrey; Geliebter, Ari; DiLorenzo, Teresa P.

In: Immunology, Vol. 131, No. 4, 12.2010, p. 459-465.

Research output: Contribution to journalArticle

Babad, Jeffrey ; Geliebter, Ari ; DiLorenzo, Teresa P. / T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes. In: Immunology. 2010 ; Vol. 131, No. 4. pp. 459-465.
@article{913c0a8372c2444fab979d68e578895b,
title = "T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes",
abstract = "Summary: The non-obese diabetic (NOD) mouse model of autoimmune (type 1) diabetes has contributed greatly to our understanding of disease pathogenesis and has facilitated the development and testing of therapeutic strategies to combat the disease. Although the model is a valuable immunological tool in its own right, it reaches its fullest potential in areas where its findings translate to the human disease. Perhaps the foremost example of this is the field of T-cell antigen discovery, from which diverse benefits can be derived, including the development of antigen-specific disease interventions. The majority of NOD T-cell antigens are also targets of T-cell autoimmunity in patients with type 1 diabetes, and several of these are currently being evaluated in clinical trials. Here we review the journeys of these antigens from bench to bedside. We also discuss several recently identified NOD T-cell autoantigens whose translational potential warrants further investigation.",
keywords = "Autoantigens, Autoimmune diabetes, Non-obese diabetic mice, Therapies, Type 1 diabetes",
author = "Jeffrey Babad and Ari Geliebter and DiLorenzo, {Teresa P.}",
year = "2010",
month = "12",
doi = "10.1111/j.1365-2567.2010.03362.x",
language = "English (US)",
volume = "131",
pages = "459--465",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes

AU - Babad, Jeffrey

AU - Geliebter, Ari

AU - DiLorenzo, Teresa P.

PY - 2010/12

Y1 - 2010/12

N2 - Summary: The non-obese diabetic (NOD) mouse model of autoimmune (type 1) diabetes has contributed greatly to our understanding of disease pathogenesis and has facilitated the development and testing of therapeutic strategies to combat the disease. Although the model is a valuable immunological tool in its own right, it reaches its fullest potential in areas where its findings translate to the human disease. Perhaps the foremost example of this is the field of T-cell antigen discovery, from which diverse benefits can be derived, including the development of antigen-specific disease interventions. The majority of NOD T-cell antigens are also targets of T-cell autoimmunity in patients with type 1 diabetes, and several of these are currently being evaluated in clinical trials. Here we review the journeys of these antigens from bench to bedside. We also discuss several recently identified NOD T-cell autoantigens whose translational potential warrants further investigation.

AB - Summary: The non-obese diabetic (NOD) mouse model of autoimmune (type 1) diabetes has contributed greatly to our understanding of disease pathogenesis and has facilitated the development and testing of therapeutic strategies to combat the disease. Although the model is a valuable immunological tool in its own right, it reaches its fullest potential in areas where its findings translate to the human disease. Perhaps the foremost example of this is the field of T-cell antigen discovery, from which diverse benefits can be derived, including the development of antigen-specific disease interventions. The majority of NOD T-cell antigens are also targets of T-cell autoimmunity in patients with type 1 diabetes, and several of these are currently being evaluated in clinical trials. Here we review the journeys of these antigens from bench to bedside. We also discuss several recently identified NOD T-cell autoantigens whose translational potential warrants further investigation.

KW - Autoantigens

KW - Autoimmune diabetes

KW - Non-obese diabetic mice

KW - Therapies

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=78149375691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149375691&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2567.2010.03362.x

DO - 10.1111/j.1365-2567.2010.03362.x

M3 - Article

C2 - 21039471

AN - SCOPUS:78149375691

VL - 131

SP - 459

EP - 465

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 4

ER -